Regulations.gov document
Agency Information Collection Activities; Announcement of OMB Approval; CGMP Regulations…
Notice · FDA-2002-N-0316 · posted Aug 28, 2017
Key facts
| Document ID | FDA-2002-N-0316-0004 |
|---|---|
| Title | Agency Information Collection Activities; Announcement of OMB Approval; CGMP Regulations for Finished Pharmaceuticals |
| Document type | Notice |
| Subtype | Notice of Approval |
| Agency | FDA |
| Docket | FDA-2002-N-0316 |
| Posted | Aug 28, 2017 |
| Federal Register citation | 67 FR 55020 |
| FR document number | 02–21735 |
| Comment period opens | Aug 28, 2017 |
| Effective date | Aug 21, 2002 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: